Pharmacoeconomic Research

2 months ago | jamanetwork.com | Ivo Abraham |Pharmacoeconomic Research |Karen Macdonald

The Evolving Landscape of Biologics—Biosimilars, Biobetters, and Bioparallels The introduction of biosimilars, first in Europe in 2006 and followed by the US in 2015, marked a pivotal shift in access to and equity in biological therapy.

Jun 30, 2023 | link.springer.com | Pharmacoeconomic Research

AbstractIntroductionLow health literacy (HL) is consistently associated with worse health outcomes. Routine clinical screening with available instruments is impractical because of added time and effort. Prior findings suggested that signature time may be a reliable alternative measure of HL among general medicine patients.